GERON CORP 10-Q — AI Bull & Bear Analysis

The Q1 2026 filing presents a company at a crossroads between successful commercial scaling and structural financial instability. On one hand, the growth in RYTELO sales and the ability to reach a near-breakeven operating point suggest that the commercial engine is functioning. On the other hand, the rising cost of sales and the persistence of net losses highlight the difficulty of transitioning to a self-sustaining business model. Investors are now weighing the potential of the European expansion and the IMpactMF trial results against the risks of debt covenants and litigation settlements. The critical metric moving forward will be whether Geron can stabilize its gross-to-net adjustments and maintain revenue growth without further equity dilution or reliance on additional debt tranches.